X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CURRENT GENE THERAPY

期刊標題檢索 CURR GENE THER 最新評論: Submission success rate: 50.0 Experience sharing: ridiculously slow, ... (2024-04-17)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CURRENT GENE THERAPY]您好,您是該頁面的第 20084 位訪客。

期刊簡介
期刊名稱CURRENT GENE THERAPY CURRENT GENE THERAPY
LetPub Score
5.1
50 ratings
Rate

Reputation
6.3

Influence
3.8

Speed
7.0

期刊簡稱CURR GENE THER
ISSN1566-5232
E-ISSN1875-5631
h-index65
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.700.6740.597
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Genetics (clinical)
Q228 / 99
Category: Medicine
Subcategory: Genetics
Q2107 / 347
Category: Medicine
Subcategory: Drug Discovery
Q254 / 157
Category: Medicine
Subcategory: Molecular Medicine
Q271 / 178
Category: Medicine
Subcategory: Molecular Biology
Q2175 / 410

自引率 (2023-2024)2.60%自引率趨勢
掲載範囲
Current Gene Therapy is a bi-monthly peer-reviewed journal aimed at academic and industrial scientists with an interest in major topics concerning basic research and clinical applications of gene and cell therapy of diseases. Cell therapy manuscripts can also include application in diseases when cells have been genetically modified. Current Gene Therapy publishes full-length/mini reviews and original research on the latest developments in gene transfer and gene expression analysis, vector development, cellular genetic engineering, animal models and human clinical applications of gene and cell therapy for the treatment of diseases.

Current Gene Therapy publishes reviews and original research containing experimental data on gene and cell therapy. The journal also includes manuscripts on technological advances, ethical and regulatory considerations of gene and cell therapy. Reviews should provide the reader with a comprehensive assessment of any area of experimental biology applied to molecular medicine that is not only of significance within a particular field of gene therapy and cell therapy but also of interest to investigators in other fields. Authors are encouraged to provide their own assessment and vision for future advances. Reviews are also welcome on late breaking discoveries on which substantial literature has not yet been amassed. Such reviews provide a forum for sharply focused topics of recent experimental investigations in gene therapy primarily to make these results accessible to both clinical and basic researchers. Manuscripts containing experimental data should be original data, not previously published.
官方網站http://benthamscience.com/journal/index.php?journalID=cgt
在線稿件提交http://bsp-cms.eurekaselect.com/index.php/CGT
開放訪問No
出版商Bentham Science Publishers B.V.
主題領域医学
出版國/地區NETHERLANDS
發行頻率四半期刊行
創刊年2001
每年文章數31每年文章數趨勢
黃金OA百分比5.88%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
GENETICS & HEREDITYSCIEQ249/191
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1566-5232%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Invited contributions ? Irregular
競爭力 *來自作者的數據: Ordinary
參考鏈接
相關期刊 【CURRENT GENE THERAPY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS GENETICSH-index: 320

    CiteScore: 57.40
    NATURE GENETICSH-index: 527

    CiteScore: 43.00
    TRENDS IN GENETICSH-index: 208

    CiteScore: 20.90
    Annual Review of GeneticsH-index: 171

    CiteScore: 18.30
    AMERICAN JOURNAL OF HUMAN GENETICSH-index: 280

    CiteScore: 14.70
    Annual Review of Genomics and Human GeneticsH-index: 104

    CiteScore: 14.90
    GENETICS IN MEDICINEH-index: 111

    CiteScore: 15.20
    PLoS GeneticsH-index: 194

    CiteScore: 8.10
    DNA RESEARCHH-index: 89

    CiteScore: 6.00
    FUNCTIONAL & INTEGRATIVE GENOMICSH-index: 66

    CiteScore: 3.50
    學科內最受檢索的期刊 頁面查看次數
    GENE315843
    NATURE GENETICS140135
    PLoS Genetics91850
    GENETICS83666
    BMC Medical Genomics67542
    BMC GENETICS60824
    AMERICAN JOURNAL OF HUMAN GENETICS60281
    HUMAN GENETICS59244
    FUNCTIONAL & INTEGRATIVE GENOMICS57887
    DNA RESEARCH54221
  •  

    CURRENT GENE THERAPY CURRENT GENE THERAPY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [CURRENT GENE THERAPY] 的評論撰寫評論
作者: 千斤雪羽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-17 20:47:50 評論於
Submission success rate: 50.0 Experience sharing: ridiculously slow, still Awaiting Editorial Approval after one month, never get replies to emails, strongly advise against submitting to this journal
(0) 讚! | 千斤雪羽

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 22:47:48 評論於
Title: Submission Column, Article Title, Published Pen Name
Content: The full content of the article.

Author information: Your real contact address, postal code, name, email address, landline phone, mobile phone, QQ number (indicate QQ name), any other contact information you think is necessary to leave (such as a brief biography
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 09:39:26 評論於
The time for major revisions of SCI papers, which usually involve additional experiments, is generally not less than two weeks and should not exceed the maximum allowed time of 90 days. Minor revisions typically take 10-20 days. Extension of deadlines can be requested based on individual circumstances
(0) 讚! | 维尔娜菲茨杰拉德

作者: 龙鳞孝礼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 09:15:39 評論於
When is the deadline for my submission? Can the deadline be changed? Is the deadline the actual required date by the journal?
(0) 讚! | 龙鳞孝礼

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 11:49:51 評論於
What are the contents included in the email for journal submission?
(0) 讚! | 北国博达

作者: 云来思若


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-10-05 13:08:11 評論於
Review speed: 3.0 | Submission acceptance rate: 50.0 Experience sharing: Submitted in November 2013, accepted in March 2014, and published in June. Submitted an article on transgenic stem cells, reviewed by three external reviewers, two responses were made, all opinions were very gentle, accepted three days after response. At that time, the impact factor was still declining after 5.3, now it's over 2. Feeling heartbroken. I remember it seemed to be a bimonthly journal, not many articles were published each year, and the publication fee was around 10,000 RMB, it was SCI-E, overall feeling is okay, graduated with a master's degree that year, felt pretty good overall~
(0) 讚! | 云来思若

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [CURRENT GENE THERAPY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*